Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01899417
Other study ID # 13-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2013
Est. completion date March 2014

Study information

Verified date October 2023
Source Restor3D
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the costs and benefits of the ConforMIS iTotal® total knee replacement system versus standard total knee arthroplasty. This study is designed to illustrate the difference in cost between standard total knee replacements and the ConforMIS iTotal at a single institution.


Description:

STUDY DESIGN The study is a two-arm single-center, consecutively enrolled retrospective study. Patients enrolled will have previously received either an iTotal CR knee replacement or a standard total knee replacement. The study site will be located in the United States. A minimum of 100 with a maximum of 120 patients will be enrolled in each study arm for a maximum of 200 - 240 patients. STUDY DURATION This study involves retrospective data collection of operative and peri-operative information to determine the cost impact of several surgical variables. The study will be complete when the retrospective data has been collected on up to 120 patients per arm.


Recruitment information / eligibility

Status Completed
Enrollment 235
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Patient has received an iTotal or a standard total knee replacement - Willingness to participate in the clinical study and to give informed consent, if necessary, as determined during IRB review - >18 years of age Exclusion Criteria: - Participation in another clinical study that could confound results - Patient is less than 3 months post-op

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ConforMIS iTotal® Knee Replacement
Patients that received a ConforMIS iTotal knee replacement versus other knee replacement devices.

Locations

Country Name City State
United States JFK Medical Center Atlantis Florida

Sponsors (1)

Lead Sponsor Collaborator
Restor3D

Country where clinical trial is conducted

United States, 

References & Publications (6)

Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010 Jan;468(1):57-63. doi: 10.1007/s11999-009-1119-9. — View Citation

Fitz W. Unicompartmental knee arthroplasty with use of novel patient-specific resurfacing implants and personalized jigs. J Bone Joint Surg Am. 2009 Feb;91 Suppl 1:69-76. doi: 10.2106/JBJS.H.01448. — View Citation

Fitzpatrick C, FitzPatrick D, Lee J, Auger D. Statistical design of unicompartmental tibial implants and comparison with current devices. Knee. 2007 Mar;14(2):138-44. doi: 10.1016/j.knee.2006.11.005. Epub 2006 Dec 22. — View Citation

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222. — View Citation

Noble PC, Conditt MA, Cook KF, Mathis KB. The John Insall Award: Patient expectations affect satisfaction with total knee arthroplasty. Clin Orthop Relat Res. 2006 Nov;452:35-43. doi: 10.1097/01.blo.0000238825.63648.1e. — View Citation

Rougraff BT, Heck DA, Gibson AE. A comparison of tricompartmental and unicompartmental arthroplasty for the treatment of gonarthrosis. Clin Orthop Relat Res. 1991 Dec;(273):157-64. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Fixed and variable costs resulting from Total Knee Arthroplasty at 30 days post-op Fixed and variable costs resulting from Total Knee Arthroplasty at 30 days post-op 1 month
Primary Fixed and variable costs resulting from Total Knee Arthroplasty at 90 days post-op Fixed and variable costs resulting from Total Knee Arthroplasty at 90 days post-op 3 months
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02784041 - Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty N/A
Completed NCT02966613 - Fully Disposable Patient-Specific Instrumentation N/A
Recruiting NCT03074994 - The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty Phase 2
Completed NCT00137410 - Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee Phase 3
Recruiting NCT03360500 - Cryotherapy Associated With Exercise in Pain Control and Physical Function in Individuals With Knee Osteoarthritis N/A
Completed NCT02967874 - Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment Phase 1/Phase 2
Completed NCT02967744 - NSAID Treatment of Patients With Osteoarthritis N/A
Completed NCT01042093 - Efficacy of Multimodal Perioperative Analgesia With Periarticular Drug Injection in Total Knee Arthroplasty(TKA) N/A
Completed NCT03033238 - Multicenter Bone and Joint Health Study
Completed NCT03011112 - Can 3D Kinematic Parameters Assess the Symptomatic and Functional Severity of KOA? N/A
Completed NCT02975154 - Microcurrent Therapy in the Treatment of Osteoarthritis of the Knee N/A
Completed NCT03684850 - Knee Brace and Biomechanical Footwear in the Treatment of Knee Osteoarthritis. N/A
Completed NCT03007576 - Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) Phase 1